Skip to main content

Luís Gros Subias

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Luís Gros Subias

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Red Temática de Investigación Cooperativa en Cáncer - RTICC

IP: Josep Sánchez de Toledo Codina
Collaborators: Soledad Gallego Melcón, Luís Gros Subias, Pablo Velasco Puyó, Aroa Soriano Fernández, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Constantino Sábado Álvarez, Anna Llort Sales, Laura Alonso Garcia, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 186750
Reference: RD12/0036/0016
Duration: 01/01/2013 - 30/06/2017

Calidad de vida en pacientes pediátricos afectos de tumores en el Sistema Nervioso Central. Papel modulador del as secuelas y de las estrategias de afrontamiento de los padres

IP: -
Collaborators: Luís Gros Subias, Constantino Sábado Álvarez, Anna Llort Sales
Funding agency: Asociación Española Contra el Cáncer
Funding: 18000
Reference: AECC 6/2008
Duration: 22/01/2009 - 21/01/2011

Identificación de nuevas dianas terapéuticas en el rabdomiosarcoma: efectos de la silenciación de las vías de señalización celular de NOTCH, Hedgehog y RAS en esta neoplasia

IP: Soledad Gallego Melcón
Collaborators: Luís Gros Subias, Constantino Sábado Álvarez, Josep Roma Castanyer
Funding agency: Asociación Española Contra el Cáncer
Funding: 18000
Reference: AECC_CAT_01_2007
Duration: 21/01/2008 - 20/01/2010

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Josep Sánchez de Toledo Codina
Collaborators: Soledad Gallego Melcón, Luís Gros Subias, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Constantino Sábado Álvarez, Anna Llort Sales, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 51990
Reference: RD06/0020/1021
Duration: 01/01/2008 - 31/12/2014

Related news

Vall d’Hebron participates as a reference centre in Spain for early-phase clinical trials and coordinates the national ReALLNet network, promoting research into relapsed acute lymphoblastic leukemia.

The PHOENIX project, involving 13 European institutions, will evaluate for the first time in paediatric patients the drug ibrilatazar from AbilityPharma in a phase I/II clinical trial.

The European initiative Hope4Kids will strengthen and harmonise paediatric palliative care across Europe, with the aim of ensuring comprehensive, high-quality care for all children living with life-threatening or life-limiting conditions.

Related professionals

Martinez Raneque, Fran

Martinez Raneque, Fran

Research assistant
Transfusional Medicine
Read more
Pascual González, Gabriel

Pascual González, Gabriel

Research assistant
Cardiovascular Diseases
Read more
Falcó Roget, Anna

Falcó Roget, Anna

Research technician
Infectious Diseases
Read more
Bragulat Arevalo, Mireia

Bragulat Arevalo, Mireia

Research technician
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.